Risk factors for high‐dose methotrexate associated toxicities in patients with primary central nervous system lymphoma
Author:
Affiliation:
1. Department of Pharmacy Huashan Hospital, Fudan University Shanghai China
2. Department of Pharmacy, Obstetrics and Gynecology Hospital Fudan University Shanghai China
3. Department of Hematology, Huashan hospital Fudan University Shanghai China
Funder
National Natural Science Foundation of China
Publisher
Hindawi Limited
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13791
Reference22 articles.
1. Impact of contemporary regimens on the outcomes and toxicity of primary CNS lymphoma: a single-center retrospective analysis of 73 patients
2. Primary central nervous system lymphoma
3. Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma
4. Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trial
5. High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study;Cancer Medicine;2024-09
2. Risk factors associated with high-dose methotrexate induced toxicities;Expert Opinion on Drug Metabolism & Toxicology;2024-03-19
3. Nanoarchitectonics of CTAB-modified kanemite as carrier of methotrexate;Applied Clay Science;2024-03
4. Predicting delayed methotrexate elimination in pediatric acute lymphoblastic leukemia patients: an innovative web-based machine learning tool developed through a multicenter, retrospective analysis;BMC Medical Informatics and Decision Making;2023-08-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3